Earnings History Data for Humanigen, Inc. (HGEN) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Humanigen, Inc.
Humanigen, Inc. is a biopharmaceutical company. It focuses on advancing medicines for patients with neglected and rare diseases. The Company's product candidate principally consists of benznidazole, lenzilumab and ifabotuzumab. Humanigen Inc., formerly known as KaloBios Pharmaceuticals Inc., is based in Brisbane, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05-05-2022 | AH | HGEN | KaloBios Pharmaceuticals | 129.00 | -0.32 | -0.49 | 0.00 | Humanigen GAAP EPS of -$0.32 beats by $0.14, revenue of $1.04M beats by $0.83M [5/5/2022 5:49 PM] |
2.15 | 0.31 (16.58%) |
1.81 | -0.03 (-1.63%) |
1.67 - 23.53 | 4,379,602 | 1,010,000 | 3,610 | ||
| 12-08-2021 | AH | HGEN | Humanigen, Inc. | 1,010 | -1.20 | -0.46 | -0.80 | Humanigen EPS misses by $0.37, beats on revenue [8/12/2021 4:58 PM] |
16.99 | -0.53 (-3.03%) |
16.80 | -0.72 (-4.11%) |
7.50 - 29.20 | 814,970 | 990,000 | 27,793 | ||
| 13-05-2021 | AH | HGEN | Kalobios Pharmaceuticals Inc. | 1,085 | -1.25 | -0.64 | 0.00 | Humanigen EPS misses by $0.61 [5/13/2021 5:10 PM] |
17.75 | 1.02 (6.10%) |
18.10 | 1.37 (8.19%) |
3.90 - 33.95 | 1,164,773 | 1,400,000 | 84,656 | ||
| 10-03-2021 | AH | HGEN | Humanigen, Inc. | 885.50 | -0.63 | -0.60 | 0.00 | Humanigen EPS beats by $0.04 [3/10/2021 5:22 PM] |
15.50 | -0.95 (-5.78%) |
16.90 | 0.45 (2.74%) |
2.25 - 33.95 | 1,336,318 | 955,859 | 17,547 | ||
|
||||||||||||||||||